{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:34:05Z","timestamp":1793144045678,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10198-023-01663-x","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T09:09:44Z","timestamp":1709024984000},"page":"1417-1435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Systematic methodological review of health state values in glaucoma cost-utility analyses"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8230-091X","authenticated-orcid":false,"given":"Kevin","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkaran","family":"Sarohia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Podbielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Eric","family":"Tarride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"1663_CR1","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond, M.F., et al.: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford (2015)"},{"issue":"7","key":"1663_CR2","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1097\/IJG.0000000000000414","volume":"25","author":"J Isenberg","year":"2016","unstructured":"Isenberg, J., Sheybani, A., Ahmed, I.I.K.: Advancing the economic assessment of microinvasive glaucoma surgery. J. Glaucoma 25(7), e721\u2013e722 (2016)","journal-title":"J. Glaucoma"},{"key":"1663_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-2733-9","volume-title":"Medical Treatment of Glaucoma","author":"X Sun","year":"2019","unstructured":"Sun, X., Dai, Y.: Medical Treatment of Glaucoma. Springer, New York (2019)"},{"issue":"1","key":"1663_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"N Zhang","year":"2021","unstructured":"Zhang, N., Wang, J., Li, Y., Jiang, B.: Prevalence of primary open angle glaucoma in the last 20 years: a meta-analysis and systematic review. Sci. Rep. 11(1), 1\u201312 (2021)","journal-title":"Sci. Rep."},{"key":"1663_CR5","volume-title":"Clinical decisions in glaucoma","author":"E Hodapp","year":"1993","unstructured":"Hodapp, E., Parrish, R.K., Anderson, D.R.: Clinical decisions in glaucoma. Mosby Incorporated (1993)"},{"issue":"47","key":"1663_CR6","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1097\/MD.0000000000005341","volume":"95","author":"G Lazcano-Gomez","year":"2016","unstructured":"Lazcano-Gomez, G., de Angeles Ramos-Cadena, M., Torres-Tamayo, M., de Oteyza, A.H., Turati-Acosta, M., Jimenez-Rom\u00e1n, J.: Cost of glaucoma treatment in a developing country over a 5-year period. Medicine 95(47), 5341 (2016)","journal-title":"Medicine"},{"issue":"2","key":"1663_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1017\/S0266462308080288","volume":"24","author":"RA Hern\u00e1ndez","year":"2008","unstructured":"Hern\u00e1ndez, R.A., Burr, J.M., Vale, L.D.: Economic evaluation of screening for open-angle glaucoma. Int. J. Technol. Assess. Health Care 24(2), 203\u2013211 (2008)","journal-title":"Int. J. Technol. Assess. Health Care"},{"issue":"11","key":"1663_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/bjophthalmol-2017-311452","volume":"102","author":"N Sharafeldin","year":"2018","unstructured":"Sharafeldin, N., Kawaguchi, A., Sundaram, A., et al.: Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults. Br. J. Ophthalmol. 102(11), 1485\u20131491 (2018)","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"1663_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s41669-019-0141-4","volume":"4","author":"J Bartelt-Hofer","year":"2020","unstructured":"Bartelt-Hofer, J., Ben-Debba, L., Flessa, S.: Systematic review of economic evaluations in primary open-angle glaucoma: decision analytic modeling insights. PharmacoEconomics Open 4(1), 5\u201312 (2020)","journal-title":"PharmacoEconomics Open"},{"issue":"5","key":"1663_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000104765","volume":"221","author":"D Koleva","year":"2007","unstructured":"Koleva, D., Motterlini, N., Schiavone, M., Garattini, L.: Medical costs of glaucoma and ocular hypertension in italian referral centres: a prospective study. Ophthalmologica 221(5), 340\u2013347 (2007)","journal-title":"Ophthalmologica"},{"issue":"8","key":"1663_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2165\/00019053-200624080-00002","volume":"24","author":"M Orme","year":"2006","unstructured":"Orme, M., Boler, A.: Prostaglandin analogues for the treatment of glaucoma and ocular hypertension. Pharmacoeconomics 24(8), 743\u2013750 (2006)","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1663_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14737167.2019.1579646","volume":"19","author":"IS Ribeiro","year":"2019","unstructured":"Ribeiro, I.S., Batel Marques, F.J., Alves, D.G., Alves, C.M.C.: A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs. Expert Rev. Pharmacoecon. Outcomes Res. 19(4), 421\u2013430 (2019)","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"issue":"1","key":"1663_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40123-018-0131-0","volume":"7","author":"P Agrawal","year":"2018","unstructured":"Agrawal, P., Bradshaw, S.E.: Systematic literature review of clinical and economic outcomes of micro-invasive glaucoma surgery (MIGS) in primary open-angle glaucoma. Ophthalmol Therapy 7(1), 49\u201373 (2018)","journal-title":"Ophthalmol Therapy"},{"issue":"3","key":"1663_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jval.2019.01.004","volume":"22","author":"J Brazier","year":"2019","unstructured":"Brazier, J., Ara, R., Azzabi, I., et al.: Identification, review, and use of health state utilities in cost-effectiveness models: An ISPOR good practices for outcomes research task force report. Value Health 22(3), 267\u2013275 (2019)","journal-title":"Value Health"},{"issue":"5","key":"1663_CR15","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ophtha.2007.06.008","volume":"115","author":"BS Lee","year":"2008","unstructured":"Lee, B.S., Kymes, S.M., Nease, R.F., Jr., Sumner, W., Siegfried, C.J., Gordon, M.O.: The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology 115(5), 898\u2013903 (2008)","journal-title":"Ophthalmology"},{"issue":"5","key":"1663_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/09286586.2020.1792938","volume":"27","author":"I Ribeiro","year":"2020","unstructured":"Ribeiro, I., Batel Marques, F., Mendes, D., Alves, C.: A systematic review of economic studies evaluating ophthalmic drugs: an analysis of the health-state utilities. Ophthalmic Epidemiol. 27(5), 325\u2013338 (2020)","journal-title":"Ophthalmic Epidemiol."},{"key":"1663_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00019053-200725020-00003","volume":"25","author":"CM McDonough","year":"2007","unstructured":"McDonough, C.M., Anna, N.A.T.: Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics 25, 93\u2013106 (2007)","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"1663_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/bjo.85.3.327","volume":"85","author":"MM Brown","year":"2001","unstructured":"Brown, M.M., Brown, G.C., Sharma, S., Kistler, J., Brown, H.: Utility values associated with blindness in an adult population. Br. J. Ophthalmol. 85(3), 327\u2013331 (2001)","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"1663_CR19","doi-asserted-by":"publisher","first-page":"E797","DOI":"10.1097\/OPX.0b013e3181339f30","volume":"84","author":"JM Burr","year":"2007","unstructured":"Burr, J.M., Kilonzo, M., Vale, L., Ryan, M.: Developing a preference-based glaucoma utility index using a discrete choice experiment. Optom. Vis. Sci. 84(8), E797\u2013E809 (2007)","journal-title":"Optom. Vis. Sci."},{"issue":"5","key":"1663_CR20","doi-asserted-by":"publisher","first-page":"0197581","DOI":"10.1371\/journal.pone.0197581","volume":"13","author":"S Choi","year":"2018","unstructured":"Choi, S., Choi, J.A., Kwon, J.W., Park, S.M., Jee, D.: Utility values for glaucoma patients in korea. PLoS ONE 13(5), 0197581 (2018)","journal-title":"PLoS ONE"},{"issue":"2","key":"1663_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00061198-200204000-00012","volume":"11","author":"HD Jampel","year":"2002","unstructured":"Jampel, H.D., Schwartz, A., Pollack, I., Abrams, D., Weiss, H., Miller, R.: Glaucoma patients\u2019 assessment of their visual function and quality of life. J. Glaucoma 11(2), 154\u2013163 (2002)","journal-title":"J. Glaucoma"},{"issue":"3","key":"1663_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1600-0420.2005.00621.x","volume":"84","author":"G Kobelt","year":"2006","unstructured":"Kobelt, G., Jonsson, B., Bergstr\u00f6m, A., Chen, E., Lind\u00e9n, C., Alm, A.: Cost-effectiveness analysis in glaucoma: What drives utility? Results from a pilot study in sweden. Acta Ophthalmol. Scand. 84(3), 363\u2013371 (2006)","journal-title":"Acta Ophthalmol. Scand."},{"issue":"4","key":"1663_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/01658100701473267","volume":"14","author":"DB Rein","year":"2007","unstructured":"Rein, D.B., Wirth, K.E., Johnson, C.A., Lee, P.P.: Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches. Ophthal. Epidemiol. 14(4), 258\u2013264 (2007)","journal-title":"Ophthal. Epidemiol."},{"key":"1663_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/00005650-200006000-00004","volume":"38","author":"TO Tengs","year":"2000","unstructured":"Tengs, T.O., Wallace, A.: One thousand health-related quality-of-life estimates. Med. Care 38, 583\u2013637 (2000)","journal-title":"Med. Care"},{"issue":"10","key":"1663_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/bjo.2005.068858","volume":"89","author":"V Gupta","year":"2005","unstructured":"Gupta, V., Srinivasan, G., Mei, S., Gazzard, G., Sihota, R., Kapoor, K.: Utility values among glaucoma patients: an impact on the quality of life. Br. J. Ophthalmol. 89(10), 1241\u20131244 (2005)","journal-title":"Br. J. Ophthalmol."},{"issue":"12","key":"1663_CR26","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/eye.2010.133","volume":"24","author":"A Van Gestel","year":"2010","unstructured":"Van Gestel, A., Webers, C., Beckers, H., et al.: The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye 24(12), 1759 (2010)","journal-title":"Eye"},{"issue":"4","key":"1663_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000350553","volume":"229","author":"C Wolfram","year":"2013","unstructured":"Wolfram, C., Lorenz, K., Breitscheidel, L., Verboven, Y., Pfeiffer, N.: Health-and vision-related quality of life in patients with ocular hypertension or primary open-angle glaucoma. Ophthalmologica 229(4), 227\u2013234 (2013)","journal-title":"Ophthalmologica"},{"key":"1663_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/OPTH.S351013","volume":"16","author":"C Lazzaro","year":"2022","unstructured":"Lazzaro, C., van Steen, C., Billeit, S., et al.: Cost-utility analysis of a latanoprost cationic emulsion (STN1013001) versus other latanoprost in the treatment of open-angle glaucoma or ocular hypertension and concomitant ocular surface disease in germany. Clin. Ophthalmol. (Auckland, NZ). 16, 323 (2022)","journal-title":"Clin. Ophthalmol. (Auckland, NZ)."},{"key":"1663_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3837471","author":"C Lazzaro","year":"2022","unstructured":"Lazzaro, C., van Steen, C., Aptel, F., Schweitzer, C., Angelillo, L.: Cost-utility analysis of STN1013001, a latanoprost cationic emulsion, versus other latanoprost formulations (latanoprost) in open-angle glaucoma or ocular hypertension and ocular surface disease in France. J. ophthalmol. (2022). https:\/\/doi.org\/10.1155\/2022\/3837471","journal-title":"J. ophthalmol."},{"issue":"1","key":"1663_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/bjc.1988.20","volume":"57","author":"ML Slevin","year":"1988","unstructured":"Slevin, M.L., Plant, H., Lynch, D., Drinkwater, J., Gregory, W.: Who should measure quality of life, the doctor or the patient? Br. J. Cancer 57(1), 109\u2013112 (1988)","journal-title":"Br. J. Cancer"},{"key":"1663_CR31","doi-asserted-by":"publisher","first-page":"S269","DOI":"10.1097\/00005650-198903001-00021","volume":"27","author":"AG Mulley Jr","year":"1989","unstructured":"Mulley, A.G., Jr.: Assessing patients\u2019 utilities: Can the ends justify the means? Med. Care 27, S269\u2013S281 (1989)","journal-title":"Med. Care"},{"issue":"6","key":"1663_CR32","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0161-6420(03)00254-9","volume":"110","author":"MM Brown","year":"2003","unstructured":"Brown, M.M., Brown, G.C., Sharma, S., Busbee, B.: Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology 110(6), 1076\u20131081 (2003)","journal-title":"Ophthalmology"},{"issue":"5","key":"1663_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0008-4182(00)80077-0","volume":"35","author":"S Sharma","year":"2000","unstructured":"Sharma, S., Brown, G.C., Brown, M.M., et al.: Converting visual acuity to utilities. Can. J. Ophthalmol. 35(5), 267\u2013272 (2000)","journal-title":"Can. J. Ophthalmol."},{"issue":"3","key":"1663_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/eurpub\/9.3.211","volume":"9","author":"L Lundberg","year":"1999","unstructured":"Lundberg, L., Johannesson, M., Isacson, D.G., Borgquist, L.: Health-state utilities in a general population in relation to age, gender and socioeconomic factors. Eur. J. Public Health 9(3), 211\u2013217 (1999)","journal-title":"Eur. J. Public Health"},{"issue":"1","key":"1663_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40273-017-0547-8","volume":"35","author":"R Ara","year":"2017","unstructured":"Ara, R., Brazier, J., Peasgood, T., Paisley, S.: The identification, review and synthesis of health state utility values from the literature. Pharmacoeconomics 35(1), 43\u201355 (2017)","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1663_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40273-017-0543-z","volume":"35","author":"R Ara","year":"2017","unstructured":"Ara, R., Peasgood, T., Mukuria, C., et al.: Sourcing and using appropriate health state utility values in economic models in health care. Pharmacoeconomics 35(1), 7\u20139 (2017)","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1663_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40273-017-0550-0","volume":"35","author":"R Ara","year":"2017","unstructured":"Ara, R., Brazier, J., Zouraq, I.A.: The use of health state utility values in decision models. Pharmacoeconomics 35(1), 77\u201388 (2017)","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1663_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s12913-016-1849-9","volume":"16","author":"T Boodhna","year":"2016","unstructured":"Boodhna, T., Crabb, D.P.: More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in england. BMC Health Serv. Res. 16(1), 611 (2016)","journal-title":"BMC Health Serv. Res."},{"issue":"1\u20134","key":"1663_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3111\/200508065084","volume":"8","author":"CL Pen","year":"2005","unstructured":"Pen, C.L., Ligier, M., Berdeaux, G.: Cost-effectiveness and cost-utility analysis of travoprost versus latanoprost and timolol in the treatment of advanced glaucoma in five european countries: Austria, france, germany, the netherlands and the united kingdom. J. Med. Econ. 8(1\u20134), 67\u201384 (2005)","journal-title":"J. Med. Econ."},{"key":"1663_CR40","doi-asserted-by":"publisher","DOI":"10.3310\/hta11410","author":"JM Burr","year":"2007","unstructured":"Burr, J.M., Mowatt, G., Hern\u00e1ndez, R.A., et al.: The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol. Assess. (2007). https:\/\/doi.org\/10.3310\/hta11410","journal-title":"Health Technol. Assess."},{"issue":"5","key":"1663_CR41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1755-3768.2007.00947.x","volume":"85","author":"H Vaahtoranta-Lehtonen","year":"2007","unstructured":"Vaahtoranta-Lehtonen, H., Tuulonen, A., Aronen, P., et al.: Cost effectiveness and cost utility of an organized screening programme for glaucoma. Acta Ophthalmol. Scand. 85(5), 508\u2013518 (2007)","journal-title":"Acta Ophthalmol. Scand."},{"issue":"1","key":"1663_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ophtha.2007.01.040","volume":"115","author":"WC Stewart","year":"2008","unstructured":"Stewart, W.C., Stewart, J.A., Nassar, Q.J., Mychaskiw, M.A.: Cost-effectiveness of treating ocular hypertension. Ophthalmology 115(1), 94\u201398 (2008)","journal-title":"Ophthalmology"},{"issue":"1","key":"1663_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3111\/13696990902728729","volume":"12","author":"J Philippe Nordmann","year":"2009","unstructured":"Philippe Nordmann, J., Lafuma, A., Berdeaux, G.: Modelling the lifetime economic consequences of glaucoma in France. J. Med. Econ. 12(1), 9\u201316 (2009)","journal-title":"J. Med. Econ."},{"issue":"1","key":"1663_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/sj.eye.6702964","volume":"23","author":"W Stewart","year":"2009","unstructured":"Stewart, W., Stewart, J., Mychaskiw, M.: Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in scandinavia and the united kingdom, using a decision-analytic health economic model. Eye 23(1), 132\u2013140 (2009)","journal-title":"Eye"},{"issue":"5","key":"1663_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/archophthalmol.2010.83","volume":"128","author":"SM Kymes","year":"2010","unstructured":"Kymes, S.M., Plotzke, M.R., Kass, M.A., Boland, M.V., Gordon, M.O.: Effect of patient\u2019s life expectancy on the cost-effectiveness of treatment for ocular hypertension. Arch. Ophthalmol. 128(5), 613\u2013618 (2010)","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"1663_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/OPX.0b013e3181fc30f3","volume":"88","author":"JS Wittenborn","year":"2011","unstructured":"Wittenborn, J.S., Rein, D.B.: The cost-effectiveness of glaucoma interventions in barbados and ghana. Optom. Vis. Sci.. Vis. Sci. 88(1), 155 (2011)","journal-title":"Optom. Vis. Sci.. Vis. Sci."},{"issue":"4","key":"1663_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archophthalmol.2011.2727","volume":"130","author":"JD Stein","year":"2012","unstructured":"Stein, J.D., Kim, D.D., Peck, W.W., Giannetti, S.M., Hutton, D.W.: Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma. Arch. Ophthalmol. 130(4), 497\u2013505 (2012)","journal-title":"Arch. Ophthalmol."},{"issue":"5","key":"1663_CR48","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1167\/iovs.12-11549","volume":"54","author":"EY Li","year":"2013","unstructured":"Li, E.Y., Tham, C.C., Chi, S.C., Lam, D.S.: Cost-effectiveness of treating normal tension glaucoma. Invest. Ophthalmol. Vis. Sci. 54(5), 3394\u20133399 (2013)","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"1663_CR49","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1167\/iovs.14-14014","volume":"55","author":"DM Blumberg","year":"2014","unstructured":"Blumberg, D.M., Vaswani, R., Nong, E., Al-Aswad, L., Cioffi, G.A.: A comparative effectiveness analysis of visual field outcomes after projected glaucoma screening using SD-OCT in african american communities. Invest. Ophthalmol. Vis. Sci. 55(6), 3491\u20133500 (2014)","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"1663_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1355819613499748","volume":"19","author":"J Burr","year":"2014","unstructured":"Burr, J., Hern\u00e1ndez, R., Ramsay, C., et al.: Is it worthwhile to conduct a randomized controlled trial of glaucoma screening in the united kingdom? J. Health Serv. Res. Policy 19(1), 42\u201351 (2014)","journal-title":"J. Health Serv. Res. Policy"},{"issue":"5","key":"1663_CR51","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1001\/jamaophthalmol.2015.44","volume":"133","author":"RI Kaplan","year":"2015","unstructured":"Kaplan, R.I., De Moraes, C.G., Cioffi, G.A., Al-Aswad, L.A., Blumberg, D.M.: Comparative cost-effectiveness of the baerveldt implant, trabeculectomy with mitomycin, and medical treatment. JAMA ophthalmology. 133(5), 560\u2013567 (2015)","journal-title":"JAMA ophthalmology."},{"issue":"9","key":"1663_CR52","doi-asserted-by":"publisher","first-page":"0137913","DOI":"10.1371\/journal.pone.0137913","volume":"10","author":"S Thomas","year":"2015","unstructured":"Thomas, S., Hodge, W., Malvankar-Mehta, M.: The cost-effectiveness analysis of teleglaucoma screening device. PLoS ONE 10(9), 0137913 (2015)","journal-title":"PLoS ONE"},{"issue":"52","key":"1663_CR53","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1097\/MD.0000000000005745","volume":"95","author":"RAP Guedes","year":"2016","unstructured":"Guedes, R.A.P., Guedes, V.M.P., Mello Gomes, C.E., de, Chaoubah A: Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity. Medicine 95(52), 5745 (2016)","journal-title":"Medicine"},{"key":"1663_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.09.1558","author":"IIK Ahmed","year":"2019","unstructured":"Ahmed, I.I.K., Podbielski, D.W., Patel, V., et al.: A canadian cost-utility analysis of two trabecular micro-bypass stents at time of cataract surgery in patients with open-angle glaucoma. Ophthalmol. Glaucoma (2019). https:\/\/doi.org\/10.1016\/j.jval.2018.09.1558","journal-title":"Ophthalmol. Glaucoma"},{"issue":"2","key":"1663_CR55","doi-asserted-by":"publisher","first-page":"e14026","DOI":"10.1097\/MD.0000000000014026","volume":"98","author":"JA Choi","year":"2019","unstructured":"Choi, J.A., Song, L.D., Choi, S., Park, S.M., Kwon, J.W., Jee, D.: The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in south korea. Medicine 98(2), e14026 (2019)","journal-title":"Medicine"},{"key":"1663_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.09.041","author":"PA Newman-Casey","year":"2019","unstructured":"Newman-Casey, P.A., Salman, M., Lee, P.P., Gatwood, J.D.: Cost-utility analysis of glaucoma medication adherence. Ophthalmology (2019). https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.041","journal-title":"Ophthalmology"},{"issue":"2","key":"1663_CR57","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/03007995.2018.1506022","volume":"35","author":"JE Ord\u00f3\u00f1ez","year":"2019","unstructured":"Ord\u00f3\u00f1ez, J.E., Ord\u00f3\u00f1ez, A., Osorio, U.M.: Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in colombia. Curr. Med. Res. Opin. 35(2), 329\u2013340 (2019)","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"1663_CR58","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/13696998.2019.1572013","volume":"22","author":"V Patel","year":"2019","unstructured":"Patel, V., Ahmed, I., Podbielski, D., Falvey, H., Murray, J., Goeree, R.: Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in canada. J. Med. Econ. 22(4), 390\u2013401 (2019)","journal-title":"J. Med. Econ."},{"issue":"7","key":"1663_CR59","doi-asserted-by":"publisher","first-page":"e968","DOI":"10.1016\/S2214-109X(19)30201-3","volume":"7","author":"J Tang","year":"2019","unstructured":"Tang, J., Liang, Y., O\u2019Neill, C., Kee, F., Jiang, J., Congdon, N.: Cost-effectiveness and cost-utility of population-based glaucoma screening in china: a decision-analytic markov model. Lancet Glob. Health 7(7), e968\u2013e978 (2019)","journal-title":"Lancet Glob. Health"},{"key":"1663_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-020-01314-7","author":"J Bartelt-Hofer","year":"2020","unstructured":"Bartelt-Hofer, J., Flessa, S.: Comparative efficacy and cost\u2013utility of combined cataract and minimally invasive glaucoma surgery in primary open-angle glaucoma. Int. Ophthalmol.Ophthalmol. (2020). https:\/\/doi.org\/10.1007\/s10792-020-01314-7","journal-title":"Int. Ophthalmol.Ophthalmol."},{"issue":"1","key":"1663_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-021-06862-x","volume":"21","author":"AM Fea","year":"2021","unstructured":"Fea, A.M., Cattel, F., Gandolfi, S., Buseghin, G., Furneri, G., Costagliola, C.: Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle glaucoma in italy. BMC Health Serv. Res. 21(1), 1\u201312 (2021)","journal-title":"BMC Health Serv. Res."},{"issue":"6","key":"1663_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252130","volume":"16","author":"K Nieland","year":"2021","unstructured":"Nieland, K., Labb\u00e9, A., Schweitzer, C., et al.: A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in france. PLoS ONE 16(6), e0252130 (2021)","journal-title":"PLoS ONE"},{"issue":"4","key":"1663_CR63","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/17469899.2021.1939685","volume":"16","author":"MA Teus","year":"2021","unstructured":"Teus, M.A., Belda, J.I., Lavin, C., et al.: Cost-effectiveness analysis of iStent inject implantation during cataract surgery compared to cataract surgery alone for mild to moderate open-angle glaucoma patients in spain. Expert Rev. Ophthalmol. 16(4), 319\u2013328 (2021)","journal-title":"Expert Rev. Ophthalmol."},{"issue":"1","key":"1663_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013254","volume":"7","author":"M Javanbakht","year":"2017","unstructured":"Javanbakht, M., Azuara-Blanco, A., Burr, J.M., et al.: Early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: an economic evaluation based on data from the EAGLE trial. BMJ Open 7(1), e013254 (2017)","journal-title":"BMJ Open"},{"issue":"31","key":"1663_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23310","volume":"23","author":"G Gazzard","year":"2019","unstructured":"Gazzard, G., Konstantakopoulou, E., Garway-Heath, D., et al.: Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: The LiGHT RCT. Health Technol. Assess. (Winchester, England). 23(31), 1 (2019)","journal-title":"Health Technol. Assess. (Winchester, England)."},{"issue":"72","key":"1663_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta25720","volume":"25","author":"AJ King","year":"2021","unstructured":"King, A.J., Fernie, G., Hudson, J., et al.: Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT. Health Technol. Assess. 25(72), 1\u2013158 (2021)","journal-title":"Health Technol. Assess."},{"issue":"5","key":"1663_CR67","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ophtha.2008.12.056","volume":"116","author":"DB Rein","year":"2009","unstructured":"Rein, D.B., Wittenborn, J.S., Lee, P.P., et al.: The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the united states. Ophthalmology 116(5), 823\u2013832 (2009)","journal-title":"Ophthalmology"},{"issue":"29","key":"1663_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16290","volume":"16","author":"JM Burr","year":"2012","unstructured":"Burr, J.M., Botello-Pinzon, P., Takwoingi, Y., et al.: Surveillance for ocular hypertension: an evidence synthesis and economic evaluation. Health Technol. Assess. 16(29), 1\u2013271 (2012)","journal-title":"Health Technol. Assess."},{"issue":"1","key":"1663_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1755-3768.2011.02318.x","volume":"90","author":"A van Gestel","year":"2012","unstructured":"van Gestel, A., Webers, C.A., Severens, J.L., et al.: The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma. Acta Ophthalmol. 90(1), 20\u201331 (2012)","journal-title":"Acta Ophthalmol."},{"issue":"8","key":"1663_CR70","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1177\/0272989X13478195","volume":"33","author":"GJ Crane","year":"2013","unstructured":"Crane, G.J., Kymes, S.M., Hiller, J.E., Casson, R., Martin, A., Karnon, J.D.: Accounting for costs, QALYs, and capacity constraints: Using discrete-event simulation to evaluate alternative service delivery and organizational scenarios for hospital-based glaucoma services. Med. Decis. Mak.Mak. 33(8), 986\u2013997 (2013)","journal-title":"Med. Decis. Mak.Mak."},{"issue":"6","key":"1663_CR71","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/aos.12328","volume":"92","author":"A van Gestel","year":"2014","unstructured":"van Gestel, A., Schouten, J.S., Beckers, H.J., Severens, J.L., Hendrikse, F., Webers, C.A.: The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension. Acta Ophthalmol. 92(6), 513\u2013523 (2014)","journal-title":"Acta Ophthalmol."},{"issue":"9","key":"1663_CR72","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1136\/bjophthalmol-2015-306757","volume":"100","author":"R Hern\u00e1ndez","year":"2016","unstructured":"Hern\u00e1ndez, R., Burr, J., Vale, L., et al.: Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective. Br. J. Ophthalmol. 100(9), 1263\u20131268 (2016)","journal-title":"Br. J. Ophthalmol."},{"key":"1663_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-021-00312-4","author":"PR Healey","year":"2021","unstructured":"Healey, P.R., Tilden, D., Jackson, D., Aghajanian, L.: A cost-utility analysis of trabecular bypass devices versus usual care for patients with open-angle glaucoma. PharmacoEconomics Open (2021). https:\/\/doi.org\/10.1007\/s41669-021-00312-4","journal-title":"PharmacoEconomics Open"},{"issue":"7","key":"1663_CR74","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1097\/IJG.0000000000000313","volume":"25","author":"X Xu","year":"2016","unstructured":"Xu, X., Ma, Y.Y., Zou, H.D.: Cost-utility analysis of cataract surgery in advanced glaucoma patients. J. Glaucoma 25(7), e657\u2013e662 (2016)","journal-title":"J. Glaucoma"},{"key":"1663_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.puhe.2017.02.016","volume":"148","author":"D John","year":"2017","unstructured":"John, D., Parikh, R.: Cost-effectiveness and cost utility of community screening for glaucoma in urban India. Public Health 148, 37\u201348 (2017)","journal-title":"Public Health"},{"key":"1663_CR76","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.puhe.2017.11.004","volume":"155","author":"D John","year":"2018","unstructured":"John, D., Parikh, R.: Cost-effectiveness of community screening for glaucoma in rural India: a decision analytical model. Public Health 155, 142\u2013151 (2018)","journal-title":"Public Health"},{"issue":"3","key":"1663_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/jop.2018.0114","volume":"35","author":"GC Brown","year":"2019","unstructured":"Brown, G.C., Brown, M.M.: Patient preference-based comparative effectiveness and cost-utility analysis of the prostamides for open-angle glaucoma. J. Ocul. Pharmacol. Ther. 35(3), 145\u2013160 (2019)","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"7","key":"1663_CR78","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/bjo.2008.139295","volume":"93","author":"X Sun","year":"2009","unstructured":"Sun, X., Zhang, S., Wang, N., et al.: Utility assessment among patients of primary angle closure\/glaucoma in china: a preliminary study. Br. J. Ophthalmol. 93(7), 871\u2013874 (2009)","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"1663_CR79","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/07853890109002086","volume":"33","author":"H Sintonen","year":"2001","unstructured":"Sintonen, H.: The 15D instrument of health-related quality of life: properties and applications. Ann. Med. 33(5), 328\u2013336 (2001)","journal-title":"Ann. Med."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-023-01663-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-023-01663-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-023-01663-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T18:05:43Z","timestamp":1727719543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-023-01663-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1007\/s10198-023-01663-x","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was exempt from ethical review due to it being a review of the literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}